Preimplantation Genetic Diagnosis Market:Growing Preference for Delayed Pregnancies Encourages Parents-to-Be to Opt for Preimplantation Genetic Diagnosis
Players in the global preimplantation genetic diagnosis (PGD) market have found it exceptionally difficult to expand their geographical reach due to a wide presence of local clinics. However, the market has an opportunity to grow, if it finds a way to tackle this restraint. For instance, smaller companies such as Genea Ltd., Reproductive Genetic Institute, Genesis Genetics, and Reprogenetics LLC are focused towards developing improved technologies for preimplantation genetic diagnosis for several other applications. Companies are also aiming at collaborating...
View full press release